USCIS to stop accepting the TB skin test
Beginning October 1, 2018, the tuberculin skin test (TST) will no longer be accepted for US Citizenship and Immigration Services (USCIS) immigration exams (1). All US civil surgeons must use a TB blood test (interferon-gamma release assay or IGRA) as the initial screening method when a test for cell-mediated immunity to TB is required. This new requirement aligns with current CDC recommendations stating that IGRA testing is strongly preferred for those who are BCG-vaccinated.
Watch a free webinar on USCIS guidelines with Dr. Alawode Oladele
Watch our free on-demand webinar to learn more about the new IGRA requirement and additional details on the updated Technical Instructions. Learn how to interpret and manage IGRA results, and why this change is an important step in the CDC’s march toward TB elimination in the US. Dr. Oladele is the medical director of county-wide services for the DeKalb County Board of Health, Georgia, where he directs medical screening of 1,000–2,000 refugees annually.
Discover the benefits of the world’s leading IGRA, QuantiFERON-TB Gold Plus
- Unlike the TST, QFT-Plus does not cross-react with the BCG vaccine – resulting in fewer false positive test results
- TB testing with QFT-Plus is accurate, affordable and available in-office through your current lab service provider
Find out more about QFT-Plus at our Provider Resources Portal
1. Emily Jentes. Immigrant, Refugee, and Migrant Health Branch, US Centers for Disease Control and Prevention. "News/Update: Tuberculosis IGRA testing for US civil surgeons". 16th February, 2018.